NEUROACTIVE 19-ALKOXY-17-SUBSTITUTED STEROIDS, PRODRUGS THEREOF, AND METHODS OF TREATMENT USING SAME

INTERMEDIATE COMPOUND AND PREPARATION METHOD THEREFOR AND APPLICATION THEREOF

C-20 STEROID COMPOUNDS, COMPOSITIONS AND USES THEREOF TO TREAT TRAUMATIC BRAIN INJURY (TBI), INCLUDING CONCUSSIONS

7-KETOLITHOCHOLIC ACID INTERMEDIATE, SYNTHESIS METHOD THEREFOR, AND APPLICATION THEREOF

-ent-19-norprogesterone, compositions and uses thereof to treat traumatic brain injury (TBI), including concussions-

PROCESSES OF MAKING ONAPRISTONE AND INTERMEDIATES THEREOF

NEUROACTIVE STEROIDS, COMPOSITIONS AND USES THEREOF

NEUROACTIVE 19-ALKOXY-17-SUBSTITUTED STEROIDS, PRODRUGS THEREOF, AND METHODS OF TREATMENT USING SAME

METHOD FOR SYNTHESIZING URSODEOXYCHOLIC ACID USING BA AS RAW MATERIAL

Neuroactive steroids, compositions, and uses thereof

NEUROACTIVE 19-ALKOXY-17-SUBSTITUTED STEROIDS, PRODRUGS THEREOF, AND METHODS OF TREATMENT USING SAME

Methods for onapristone synthesis dehydration and deprotection

Intermediates for the synthesis of bile acid derivatives, in particular of obeticholic acid

Neuroactive steroids, compositions, and uses thereof

METHOD FOR PREPARING A FARNESOID X RECEPTOR AGONIST

DEUTERATED FORMS OF AMINOSTEROLS AND METHODS OF USING THE SAME

Intermediates for the synthesis of bile acid derivatives, in particular of obeticholic acid

Neuroactive steroids, compositions, and uses thereof

Cytotoxic agents that preferentially target leukemia inhibitory factor (LIF) for the treatment of malignancies and as new contraceptive agents

Method for preparing a farnesoid X receptor agonist

PROGESTERONE ANTAGONISTS

METHODS FOR ONAPRISTONE SYNTHESIS DEHYDRATION AND DEPROTECTION

Method for fully automated synthesis of 16β-F-fluoro-5α-dihydrotestosterone (F-FDHT)

Neuroactive steroids, compositions, and uses thereof

Neuroactive 19-alkoxy-17-substituted steroids, prodrugs thereof, and methods of treatment using same

Neuroactive 19-alkoxy-17-substituted steroids, prodrugs thereof, and methods of treatment using same

Industrial process for the synthesis of ulipristal acetate and its 4′-acetyl analogue

Cytotoxic agents that preferentially target leukemia inhibitory factor (LIF) for the treatment of malignancies and as new contraceptive agents

Combination of estrogens plus antiprogestins with significant partial agonistic effect as an effective treatment of menopausal symptoms and for prevention of the occurrence of breast cancer

NOVEL COMPOUNDS OF 11BETA-HYDROXY-STEROIDS FOR USE IN MITOCHONDRIA BIOGENESIS AND DISEASES ASSOCIATED WITH MITOCHONDRIAL DYSFUNCTION OR DEPLETION

Estrogen receptor imaging agents

Process for preparing 11-methylene-18-methyl-estr-4-en-3, 17-dione, useful as intermediate compound for the synthesis of molecules having pharmacological activity

Method for preparing ulipristal acetate and key intermediate thereof

Neuroactive 19-alkoxy-17-substituted steroids, prodrugs thereof, and methods of treatment using same

METHODS FOR PREPARING SYNTHETIC BILE ACIDS AND COMPOSITIONS COMPRISING THE SAME

PROGESTERONE RECEPTOR ANTAGONISTS AND USES THEREOF

Process for preparing delta-7,9(11) steroids from and analogs thereof

PROGESTERONE ANTAGONISTS

17-hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-benzylidene derivatives, methods for the production thereof and use thereof for treating diseases

17-hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-aryl derivatives, methods for the production thereof and the use thereof for treating diseases

17-hydroxy-17-pentafluoroethyl-estra-4,9(10)-diene-11-ethynylphenyl derivatives, methods for the production thereof and use thereof for treating diseases

Method of making and using 7α, 11β-dimethyl-17β-hydroxyestr-4-en-3-one 17-undecanoate

Industrial method for the synthesis of 17-acetoxy-11β[4-(dimethylamino)-phenyl]-21-methoxy-19-norpregna-4,9-dien-3,20-dione and the key intermediates of the process

21-substituted progesterone derivatives as new antiprogestational agents

Industrial process for the synthesis of 17α-acetoxy-11β-[4-(N,N-dimethyl-amino)-phenyl]-19-norpregna-4,9-diene-3,20-dione and new intermediates of the process

METHOD OF MAKING AND USING 7alpha,11beta-DIMETHYL-17beta-HYDROXYESTR-4-EN-3-ONE 17-UNDECANOATE

Progesterone receptor antagonists

Process for the preparation of 21-hydroxy steroids with control of the epimeric distribution at the C-21 position

Process for preparing guggulsterones and guggulsterol

21-substituted progesterone derivatives as new antiprogestational agents

Regioselective and stereoselective oxidation of fused ring systems useful for the preparation of aminosterols

Structural modification of 19-norprogesterone I: 17-α-substituted-11-β-substituted-4-aryl and 21-substituted 19-norpregnadienedione as new antiprogestational agents

21-substituted progesterone derivatives as new antiprogestational agents

Method of making and using 7alpha,11beta-dimethyl-17beta-hydroxyestr-4-en-3-one 17-undecanoate